Ron Stotish, chief executive officer of AquaBounty, the company that applied with the Food and Drug Administration to market genetically modified salmon, speaks to reporters during a break at an FDA advisory committee hearing in Rockville, Md., Monday, Sept. 20, 2010. (AP Photo/Charles Dharapak)

Photo by: Charles Dharapak

Ron Stotish, chief executive officer of AquaBounty, the company that applied with the Food and Drug Administration to market genetically modified salmon, speaks to reporters during a break at an FDA advisory committee hearing in Rockville, Md., Monday, Sept. 20, 2010. (AP Photo/Charles Dharapak)